“Stem wave therapy” is a marketing term used by some clinics to describe extracorporeal shock wave therapy (ESWT) applied to the knee, usually for osteoarthritis or tendon problems. The “stem” part of the name references research showing that acoustic pressure waves can stimulate the body’s own stem cells and progenitor cells, but the therapy itself does not inject stem cells or use any biological material. It is, at its core, a device-based treatment that sends focused or radial pressure pulses into tissue. The rebranding has caused real confusion, and the science behind what these waves actually do to a knee joint is more nuanced than most clinic websites suggest.
What the Device Actually Does
Shock wave therapy delivers brief, high-pressure acoustic pulses into tissue through the skin. A handheld applicator is pressed against the knee, and pulses travel into the targeted area. When those pressure waves hit tissue, they do not work by physically breaking anything apart the way kidney-stone lithotripsy does. Instead, cells in the path of the wave experience a rapid stretch-and-compress cycle. That mechanical stimulus triggers a cascade of biological signaling inside the cells, a process researchers call mechanotransduction.
The biological effects are not one single response but a collection of them. Research has identified several key pathways that get switched on: the formation of new blood vessels, recruitment and activation of stem cells already resident in the tissue, changes in inflammatory signaling, and a dampening of pain nerve activity.
How Pressure Waves Trigger Biological Changes
When a shock wave hits a cell membrane, it activates sensors on the cell surface. In endothelial cells (the cells lining blood vessels), this includes proteins that detect mechanical force and translate it into chemical signals inside the cell. That chain of internal signals promotes the growth of new blood vessels and increases production of growth factors like vascular endothelial growth factor (VEGF).
Animal studies have confirmed that shock wave treatment increases VEGF levels and the number of capillaries in treated tissue. In one ischemia model, treated muscles showed elevated levels of both VEGF and another growth-factor signal that attracts endothelial progenitor cells to the area, resulting in measurably more capillaries than untreated controls.
This vascular response matters for knee osteoarthritis because cartilage is famously bad at healing on its own, partly due to its limited blood supply. By stimulating new vessel growth in the subchondral bone just beneath the cartilage surface, shock waves may improve the nutrient environment for cartilage repair.
Where the “Stem” Part Comes In
The name “stem wave therapy” is not entirely fabricated from thin air. ESWT has demonstrated an ability to enhance the proliferation, differentiation, migration, and recruitment of stem cells in laboratory and animal studies. A 2024 review in Stem Cell Research & Therapy described this as offering “new possibilities for utilizing ESWT in conjunction with stem cells for the treatment of different systemic conditions.”
In a rat knee model, radial shock waves promoted the self-renewal of subchondral bone stem/progenitor cells and facilitated cartilage repair. The shock wave treatment boosted cell proliferation without increasing cell death, and the resulting cartilage showed improved composition at follow-up.
That said, the leap from “shock waves can stimulate resident stem cells in animal tissue” to “this is stem cell therapy for your knee” is a big one. No external stem cells are delivered. No harvesting or injection occurs. The therapy nudges cells that are already present in your bone and joint tissues to become more active. Some clinics lean into the stem-cell branding because it sounds cutting-edge, but the American medical establishment has not adopted the term, and calling ESWT “stem wave therapy” can mislead patients into thinking they are receiving an injection-based regenerative treatment.
Effects on Pain and Inflammation in the Knee
For people with knee osteoarthritis, pain relief is usually the main reason to consider this treatment. Shock waves appear to reduce pain through more than one channel. A 2025 mechanistic review found that ESWT may lower the excitability of sensory nerves and reduce the signaling of pain-related neuropeptides like substance P. It also described changes in inflammatory mediators and enzymes involved in cartilage breakdown, suggesting the treatment addresses both the pain signal and some of the underlying inflammatory process driving cartilage damage.
Preclinical studies have reported shifts in the balance of matrix metalloproteinases (enzymes that chew up cartilage) and their inhibitors, pointing toward a more protective biochemical environment in the joint after treatment. One study evaluating ESWT as a regenerative approach for knee osteoarthritis found that pain scores decreased significantly over the treatment period.
What Happens to Cartilage and Bone
Several animal studies have looked at what shock waves do to the actual structure of a knee joint. In rat models of osteoarthritis, ESWT improved subchondral bone repair on micro-CT imaging compared to untreated osteoarthritic knees. Cartilage damage was also reduced, with treated joints showing less surface damage and less proteoglycan loss.
A 2024 study in rats with osteochondral defects took this further, finding that focused shock wave therapy led to increased type II collagen (the type you want in healthy cartilage) and decreased type I collagen (the type associated with scar-like repair tissue) in newly formed cartilage. Key growth factors involved in cartilage and bone formation were significantly elevated at twelve weeks compared to untreated defects.
These are encouraging findings, but it is worth noting that nearly all of this structural evidence comes from animal models. Whether the same degree of cartilage regeneration occurs in human knees, which are larger and bear far more weight, remains an open and actively studied question.
Clinical Evidence for Knee Osteoarthritis
Multiple systematic reviews and meta-analyses have examined whether ESWT helps people with knee osteoarthritis in practice. A meta-analysis of randomized clinical trials found moderate-quality evidence that ESWT reduces pain on a visual analogue scale by a clinically meaningful amount and improves scores on the WOMAC index, which measures pain, stiffness, and physical function.
Another meta-analysis reported that patients in ESWT groups had significantly lower pain scores than control groups both within two weeks of treatment and at six months, with better functional outcomes in the weeks following treatment. That review also noted no rebound pain for up to twelve months.
A separate systematic review and meta-analysis found significant improvements in both pain relief and physical function lasting up to twelve months, with only minor complications observed. Taken together, these reviews paint a consistent picture: ESWT provides meaningful short-to-medium-term pain relief and functional improvement for knee osteoarthritis, with effects that appear to hold for several months at minimum.
The evidence is weaker for some other knee conditions. For patellar tendinopathy, the picture is mixed. A network meta-analysis of randomized studies found that ESWT did not appear superior to sham treatment when both groups also performed eccentric exercises. However, a review of chronic patellar tendinopathy that has failed conservative treatment described ESWT as effective and safe, especially when combined with eccentric exercises and standardized physical therapy rather than used in isolation.
Focused Versus Radial Devices
Not all shock wave machines work the same way. The two main types are focused and radial. Focused devices generate a true shock wave that converges on a small, deep target point, concentrating energy at a specific depth. Radial devices produce a pressure wave that spreads outward from the tip of the applicator, dispersing energy as it penetrates deeper into tissue.
Because the energy distribution differs, the biological effects may not be identical. A randomized trial comparing the two types for rotator cuff tendinopathy noted that radial shock waves are lower-to-medium energy and lose pressure as they travel deeper, meaning their tissue effects may differ from focused waves. For knee osteoarthritis specifically, both types have been used in clinical trials, but head-to-head comparisons in the knee are still limited.
When clinics advertise “stem wave therapy,” the device being used could be either type. If you are considering treatment, asking whether the clinic uses a focused or radial device is a reasonable question, though neither type has been proven clearly superior for knee osteoarthritis at this point.
What a Treatment Session Looks Like
A typical ESWT protocol for knee osteoarthritis involves a handheld applicator placed against the skin over the affected area, often aimed at the proximal medial tibia (the inner side of the shinbone just below the knee). Ultrasound gel is applied for coupling, and the device delivers a set number of pulses per session.
Published protocols vary, but a common approach involves around 1,000 pulses per session at low-to-medium energy levels, performed once a week for three weeks. One pilot study used an energy flux density of 0.05 mJ/mm² with 1,000 pulses weekly for three weeks. A dose-comparison trial tested both a low-energy group at 0.040 mJ/mm² and a medium-energy group at 0.093 mJ/mm², both receiving 1,000 shocks per session once weekly for three weeks, targeting the medial tibial plateau.
Sessions typically last around fifteen to twenty minutes. Some discomfort during treatment is normal, especially at higher energy settings. Clinical guidelines for other conditions treated with ESWT recommend against using local anesthesia during sessions, as numbing the area may actually reduce the therapy’s effectiveness. A rest period between sessions also appears to improve outcomes.
Safety and Side Effects
ESWT has a strong safety profile for musculoskeletal applications. A comprehensive update published in EFORT Open Reviews described it as a safe therapy with only minor known side effects, primarily pain during treatment and small bruises. No severe complications are expected when the therapy is performed according to established protocols.
Meta-analyses focused on knee osteoarthritis have echoed this, with one reporting only minor side effects such as skin redness and swelling. The main contraindications are significant blood-clotting disorders (for high-energy treatments) and pregnancy where the shock wave focus would be near the fetus. People with metal implants near the treatment area, active infections, or tumors at the site should also avoid the treatment.
Combining Shock Waves With PRP
One of the more active areas of research is pairing ESWT with platelet-rich plasma (PRP) injections. The logic is straightforward: if shock waves prime the tissue by boosting blood supply and activating repair signals, and PRP delivers a concentrated dose of growth factors, the combination might outperform either treatment alone.
Several studies suggest this is the case. A retrospective analysis of patients with knee osteoarthritis and meniscus injuries found that combined ESWT and PRP produced significantly lower pain and disability scores than either treatment alone, along with greater range of motion and fewer complications.
A prospective study comparing PRP alone, ESWT alone, and the combination for knee osteoarthritis found that combined treatment was superior at multiple time points after treatment, with the authors concluding that the two therapies relieve pain synergistically. A randomized controlled trial in athletes with patellar tendinopathy found that PRP combined with ESWT led to faster pain reduction at one month compared to PRP alone, with both groups showing improvement over twelve months.
Combination therapy is still being optimized in terms of timing, dosing, and sequencing. But the early clinical data is promising enough that many clinics now offer pairing as an option.
Who Responds Best
Not everyone with knee osteoarthritis responds equally well to ESWT, and the emerging research on patient selection is interesting. One study specifically investigated whether the thickness and composition of soft tissue around the knee predicted treatment outcomes. The researchers found that the ratio of soft tissue thickness in certain areas around the knee was positively correlated with pain relief. In practical terms, patients whose soft tissue characteristics fell above certain thresholds experienced more pronounced benefits.
This suggests that the physical properties of the tissue between the device and the target area matter for how effectively the shock waves reach their destination, which makes sense given that pressure waves attenuate as they pass through tissue. It also hints that ESWT may work better for some knee anatomies than others, and that patient selection could eventually be refined using imaging measurements taken before treatment begins.
Stage of disease also matters. The therapy appears better suited to mild and moderate osteoarthritis than to advanced cases with severe cartilage loss. The pilot study specifically targeting mild knee osteoarthritis reported positive outcomes, and the animal research showing cartilage improvement used early-stage disease models. For end-stage knees where little cartilage remains, shock waves are unlikely to regenerate what is already gone.
FDA Clearance and What It Means for Knee Treatment
In the United States, the FDA has approved several specific shock wave devices for the treatment of plantar fasciitis and lateral epicondylitis (tennis elbow). ESWT for knee osteoarthritis does not currently carry specific FDA approval, which means its use on knees falls into an off-label category. Off-label does not mean illegal or unsupported by evidence, but it does mean insurance coverage is typically limited, and patients usually pay out of pocket.
This regulatory gap is one reason the marketing around “stem wave therapy” has flourished. Without a clear FDA-approved indication for knee use, clinics have more freedom in how they describe and brand the treatment. Some present it as a breakthrough regenerative therapy, complete with testimonials and before-and-after imaging, while the peer-reviewed evidence, though positive, is more measured. The treatment reliably reduces pain and improves function for months, and animal data on tissue repair is encouraging, but claims of full cartilage regeneration in human knees remain ahead of the published evidence.
If you are evaluating a clinic offering “stem wave therapy,” a few questions can help you gauge credibility. Ask what specific device is being used and whether it is an FDA-cleared shock wave device (even if not cleared specifically for knees). Ask about the treatment protocol, including energy level, pulse count, and number of sessions, and compare the answer to published protocols. Be cautious of clinics that promise to “regrow” cartilage or that describe the treatment as stem cell therapy without clarifying that no cells are injected.
How Body Mass and Activity Level Factor In
Practical factors beyond disease stage influence outcomes. Body composition affects how shock waves propagate through tissue, and the soft-tissue-ratio findings described earlier underscore this point. Patients carrying significant extra weight around the knee may find that pressure waves lose more energy before reaching the target structure. This does not mean ESWT cannot work for heavier patients, but clinicians may need to adjust energy settings or use focused rather than radial devices to compensate for greater tissue depth.
Activity level after treatment also plays a role. The evidence on patellar tendinopathy, for instance, consistently shows that ESWT works best as part of a broader rehabilitation program rather than as a standalone fix. For knee osteoarthritis, combining ESWT with exercise-based rehabilitation and, where appropriate, weight management is likely to produce more durable results than shock waves alone. The therapy creates a window of reduced pain and improved tissue biology, but the patient’s own movement and loading patterns determine whether that window leads to lasting functional gains or just temporary relief.